Similarly, in the multivariable MR analysis of TG–IL-17–NAFLD, the direct effect was attenuated to OR 1.250 (95% CI: 1.033–1.467, p = 0.013, Table 4). Here, IL17A is linked to metabolic dysfunction-associated steatotic liver disease.